Namrata Chand
Investor Relations Kontakt bei Ryca International, Inc.
Profil
Ms. Namrata Chand is a Vice President-Operations & Head-Communications at QSAM Biosciences, Inc. and a Head-Investor Relations & Business Development at Ryca International, Inc.
Aktive Positionen von Namrata Chand
| Unternehmen | Position | Beginn |
|---|---|---|
| Ryca International, Inc. | Investor Relations Kontakt | - |
Ehemalige bekannte Positionen von Namrata Chand
| Unternehmen | Position | Ende |
|---|---|---|
| QSAM BIOSCIENCES, INC. | Geschäftsführer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
QSAM Biosciences, Inc.
 QSAM Biosciences, Inc. Chemicals: AgriculturalProcess Industries QSAM Biosciences, Inc. engages in the provision of nuclear medicines for the treatment of cancer and related diseases and conditions. It also focuses on the development of its licensed radiopharmaceutical drug candidate, Samarium-153-DOTMP or CycloSam. The company was founded by Christopher M. Nelson, Douglas R. Baum and C. Richard Piazza on August 26, 2004 and is headquartered in Austin, TX. | Process Industries |
| Ryca International, Inc. |
